Results 31 to 40 of about 40 (40)

[Time-restricted eating as a novel strategy for treatment of obesity and it's comorbid conditions]. [PDF]

open access: yesProbl Endokrinol (Mosk), 2022
Berkovskaya MA   +3 more
europepmc   +1 more source

[Semaglutide - effectiveness in weight loss and side effects when used according to studies by SUSTAIN, PIONEER, STEP]. [PDF]

open access: yesProbl Endokrinol (Mosk), 2023
Shabutdinova OR   +10 more
europepmc   +1 more source

[Activation markers of the stress system in patients with type 1 diabetes during hypoglycemia]. [PDF]

open access: yesProbl Endokrinol (Mosk)
Karamullina RA   +5 more
europepmc   +1 more source

[Remote glycemic control using devices for wireless data transmission in children with type 1 diabetes mellitus: interim results of clinical approbation]. [PDF]

open access: yesProbl Endokrinol (Mosk)
Laptev DN   +8 more
europepmc   +1 more source

[Summary of the 2023 European Society of Cardiology clinical guidelines on the management of cardiovascular disease in patients with diabetes mellitus]. [PDF]

open access: yesProbl Endokrinol (Mosk)
Erlikh AD   +8 more
europepmc   +1 more source

[Clinical case of plurihormonal pituitary adenoma (STH/ACTH/TSH/FSH/LH-secreting), diagnostic pitfalls]. [PDF]

open access: yesProbl Endokrinol (Mosk)
Kostyleva DN   +6 more
europepmc   +1 more source

[Fixed ratio combinations GLP-1RA and basal insulin: literature review]. [PDF]

open access: yesProbl Endokrinol (Mosk)
Kurkin DV   +10 more
europepmc   +1 more source

[Evolution of insulin therapy: past, present, future]. [PDF]

open access: yesProbl Endokrinol (Mosk)
Kurkin DV   +13 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy